Ten-year experience on retransurethral resection of nonmuscle-invasive bladder cancer. Are we doing on the right patients?

被引：0
|
作者：
Wong, K. W. [1 ]
Lai, T. C. T. [1 ]
Tsang, C. F. [1 ]
Ho, B. [1 ]
Ng, A. T. L. [1 ]
Ma, W. K. [1 ]
Tsu, J. H. L. [1 ]
Yiu, M. K. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Div Urol, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
BJU INTERNATIONAL | 2017年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] Management, surveillance patterns, and costs associated with low-grade papillary (Ta) nonmuscle-invasive bladder cancer.
    Bree, Kelly K.
    Shan, Yong
    Hensley, Patrick J.
    Lobo, Niyati
    Hu, Chengrui
    Tyler, Douglas S.
    Chamie, Karim
    Kamat, Ashish M.
    Williams, Stephen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Patient and Provider Perception of Transurethral Resection of Bladder Tumor vs Chemoablation for Nonmuscle-invasive Bladder Cancer Treatment EDITORIAL COMMENTS
    Dullea, Alexandra D.
    Hougen, Helen Y.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 159 - 159
  • [23] Sequential intravesical gemcitabine and docetaxel for BCG-naive high-risk nonmuscle-invasive bladder cancer.
    McElree, Ian Mitchell
    Steinberg, Ryan L.
    Mott, Sarah L.
    Martin, Alexander C.
    Richards, Jordan
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [24] Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis
    Deb, Abdalla Ali
    Agag, Ayman
    Naushad, Naufal
    Krishnamoorthy, Rajbabu
    Serag, Hosam
    TURKISH JOURNAL OF UROLOGY, 2021, 47 (04): : 260 - +
  • [25] Predicting recurrence and progression in Australian patients with nonmuscle-invasive bladder cancer using the EORTC scoring model
    Demkiw, S.
    Mow, T.
    Duggan, G.
    Goad, J.
    Wong, L-M.
    BJU INTERNATIONAL, 2015, 115 : 56 - 56
  • [26] Long-term follow-up of intravesical gemcitabine and docetaxel as rescue therapy for nonmuscle-invasive bladder cancer.
    Chevuru, Phani T.
    McElree, Ian Mitchell
    Martin, Alexander C.
    Richards, Jordan
    Mott, Sarah L.
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    Steinberg, Ryan L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [27] Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome
    Herr, HW
    Bajorin, DF
    Scher, HI
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1298 - 1301
  • [28] Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome
    Dunst, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (02) : 86 - 87
  • [29] Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer.
    Weir, Scott James
    Kessler, Elizabeth R.
    Kukreja, Janet Baack
    Falchook, Gerald Steven
    Bupathi, Manojkumar
    Parikh, Rahul Atul
    Wulff-Burchfield, Elizabeth Marie
    Wood, Robyn
    Lee, Eugene K.
    Ham, Tammy
    Dandawate, Prasad
    Anant, Shrikant
    Woolbright, Benjamin L.
    Zhang, Na
    Toren, Paul
    Dalton, Michael
    Zhukova-Harrill, Valentina
    Umbreit, Jay Nicholas
    McCulloch, William
    Taylor, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16557 - E16557
  • [30] Ovary intraoperative consultation - are we doing the best we can? - A ten-year retrospective analysis of our experience
    Dahlstedt-Ferreira, C.
    Carralas Antunes, S.
    Oliveira, R.
    Gomes Pinto, D.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S115 - S115
12345